These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 15728942)

  • 1. In vitro activity of the histatin derivative P-113 against multidrug-resistant pathogens responsible for pneumonia in immunocompromised patients.
    Giacometti A; Cirioni O; Kamysz W; D'Amato G; Silvestri C; Del Prete MS; Licci A; Riva A; Lukasiak J; Scalise G
    Antimicrob Agents Chemother; 2005 Mar; 49(3):1249-52. PubMed ID: 15728942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing Incidence of Multidrug Resistance Among Cystic Fibrosis Respiratory Bacterial Isolates.
    Rutter WC; Burgess DR; Burgess DS
    Microb Drug Resist; 2017 Jan; 23(1):51-55. PubMed ID: 27326758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hospital-acquired pneumonia in critically ill patients: factors associated with episodes due to imipenem-resistant organisms.
    Leroy O; d'Escrivan T; Devos P; Dubreuil L; Kipnis E; Georges H
    Infection; 2005 Jun; 33(3):129-35. PubMed ID: 15940413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical importance of Stenotrophomonas maltophilia nosocomial pneumonia due to its high mortality in hemodialysis patients.
    Wakino S; Imai E; Yoshioka K; Kamayachi T; Minakuchi H; Hayashi K; Inamoto H; Itoh H
    Ther Apher Dial; 2009 Jun; 13(3):193-8. PubMed ID: 19527465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia.
    Fritsche TR; Sader HS; Stilwell MG; Dowzicky MJ; Jones RN
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):187-93. PubMed ID: 16105563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of amphibian peptides alone and in combination with antimicrobial agents against multidrug-resistant pathogens isolated from surgical wound infection.
    Giacometti A; Cirioni O; Kamysz W; Silvestri C; Licci A; Riva A; Łukasiak J; Scalise G
    Peptides; 2005 Nov; 26(11):2111-6. PubMed ID: 16269345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of ceftaroline against multidrug-resistant Staphylococcus aureus and Streptococcus pneumoniae: a review of published studies and the AWARE Surveillance Program (2008-2010).
    Farrell DJ; Castanheira M; Mendes RE; Sader HS; Jones RN
    Clin Infect Dis; 2012 Sep; 55 Suppl 3():S206-14. PubMed ID: 22903953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of MSI-78 alone and in combination with antibiotics against bacteria responsible for bloodstream infections in neutropenic patients.
    Giacometti A; Cirioni O; Kamysz W; D'Amato G; Silvestri C; Licci A; Nadolski P; Riva A; Lukasiak J; Scalise G
    Int J Antimicrob Agents; 2005 Sep; 26(3):235-40. PubMed ID: 16122911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The third-generation P-glycoprotein inhibitor tariquidar may overcome bacterial multidrug resistance by increasing intracellular drug concentration.
    Leitner I; Nemeth J; Feurstein T; Abrahim A; Matzneller P; Lagler H; Erker T; Langer O; Zeitlinger M
    J Antimicrob Chemother; 2011 Apr; 66(4):834-9. PubMed ID: 21393173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of S-(3,4-dichlorobenzyl)isothiourea hydrochloride and novel structurally related compounds against multidrug-resistant bacteria, including Pseudomonas aeruginosa and Burkholderia cepacia complex.
    Nicholson A; Perry JD; James AL; Stanforth SP; Carnell S; Wilkinson K; Anjam Khan CM; De Soyza A; Gould FK
    Int J Antimicrob Agents; 2012 Jan; 39(1):27-32. PubMed ID: 21993484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential novel therapeutic strategies in cystic fibrosis: antimicrobial and anti-biofilm activity of natural and designed α-helical peptides against Staphylococcus aureus, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia.
    Pompilio A; Crocetta V; Scocchi M; Pomponio S; Di Vincenzo V; Mardirossian M; Gherardi G; Fiscarelli E; Dicuonzo G; Gennaro R; Di Bonaventura G
    BMC Microbiol; 2012 Jul; 12():145. PubMed ID: 22823964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotype and antibiotic susceptibility patterns of Pseudomonas aeruginosa and Stenotrophomonas maltophilia isolated from cystic fibrosis patients.
    Nazik H; Ongen B; Erturan Z; Salcioğlu M
    Jpn J Infect Dis; 2007 May; 60(2-3):82-6. PubMed ID: 17515637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of distribution characteristics and drug resistance of 2748 strains of pathogens isolated from burn patients].
    Peng DZ; Liu XL; Liu ZY; Shu WT; Zhou X; Liu J; Huang YS; Wu J; Fu WL
    Zhonghua Shao Shang Za Zhi; 2012 Apr; 28(2):87-95. PubMed ID: 22781318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Interpretive reading of the non-fermenting gram-negative bacilli antibiogram].
    Vila J; Marco F
    Enferm Infecc Microbiol Clin; 2010 Dec; 28(10):726-36. PubMed ID: 20579775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential therapeutic role of histatin derivative P-113d in experimental rat models of Pseudomonas aeruginosa sepsis.
    Cirioni O; Giacometti A; Ghiselli R; Orlando F; Kamysz W; D'Amato G; Mocchegiani F; Lukasiak J; Silvestri C; Saba V; Scalise G
    J Infect Dis; 2004 Jul; 190(2):356-64. PubMed ID: 15216473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance in nonfermenting gram-negative bacteria: multidrug resistance to the maximum.
    McGowan JE
    Am J Infect Control; 2006 Jun; 34(5 Suppl 1):S29-37; discussion S64-73. PubMed ID: 16813979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative in vitro activity of Ro 09-1428, a novel cephalosporin with a catechol moiety.
    Qadri SM; Ayub A; Ueno Y; Saldin H
    Clin Ther; 1992; 14(4):562-9. PubMed ID: 1525790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pitfalls of polymyxin antimicrobial susceptibility testing of Pseudomonas aeruginosa isolated from cystic fibrosis patients.
    Hogardt M; Schmoldt S; Götzfried M; Adler K; Heesemann J
    J Antimicrob Chemother; 2004 Dec; 54(6):1057-61. PubMed ID: 15509615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of synergistic activity of bovine lactoferricin with antibiotics in corneal infection.
    Oo TZ; Cole N; Garthwaite L; Willcox MD; Zhu H
    J Antimicrob Chemother; 2010 Jun; 65(6):1243-51. PubMed ID: 20375033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.